HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
- Type
- Retraction
- Notice date
- 2/8/2023 0:00
- Journal
- Journal of Experimental & Clinical Cancer Research: (CR)
- Publisher
- Springer - Biomed Central (BMC)
- Notice DOI
- 10.1186/s13046-023-02613-4
- Original paper DOI
- 10.1186/s13046-020-01606-x